HCAR2 and Cognitive impairment: In the context of the proposed cascade, the downregulation of GPR109A (which disinhibits cPLA2 activity) contributes to the development of cognitive impairment, while the activation of GPR109A (which inhibits cPLA2) exerts nootropic effects (Figure 1 and Figure 3).